PALO ALTO, Calif., Aug. 30, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, ...
- Acoramidis demonstrated a significant reduction in risk of CVM through 42 months post-randomization, with a 44% hazard reduction, setting a new standard for CVM outcomes for patients with ATTR-CM - ...
(MENAFN- GlobeNewsWire - Nasdaq) - Acoramidis demonstrated a significant reduction in risk of CVM through 42 months post-randomization, with a 44% hazard reduction, setting a new standard for CVM ...
I am Paul, a solo-developer, which means I work on this project all by myself from design to coding to maintaing the project. so, if you'd like to support the development, you can purchase a license ...
Something like this has already been done by ParthJadhav with Tkinter Designer but I liked the concept and wanted to make something similar if not better from scratch. TkForge interacts with the Figma ...
Antitrust authorities have raised concerns that digital marketplaces favor themselves and their products relative to how they treat other third-parties, a concept known as self-preferencing. The ...
Abstract: This paper proposes a novel metric learning method for fair face attribute recognition. Datasets with imbalanced sample distributions can spoil the fair discrimination ability of deep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback